Russian Ministry of Health backs legislation to ban tobacco sales after 2009

Oct.24.2024
Russian Ministry of Health backs legislation to ban tobacco sales after 2009
Russian Ministry of Health supports a bill proposed by "New People" to ban the sale of tobacco to people born after 2009.

The Ministry of Health of the Russian Federation has declared its support for a bill proposed by the "New People" party to ban the sale of tobacco and nicotine products to individuals born after December 31, 2009, Ura.News reported on October 24.

 

"Kommersant magazine expressed the opinion that: "The project is in line with the country's basic policy of reducing tobacco and nicotine consumption. This strategy emphasises the Health Ministry's gradual phasing out of tobacco products by 2035. Although a reduction in excise tax may result in a reduction in budget revenue, the bill also takes into account the potential savings in health care costs associated with the treatment of smoking-related illnesses".

 

The media reported that the federal government's opinion on the draft law was sent to the relevant departments on 19 October 2024. In addition, the Russian Ministry of Health is also ready to support initiatives aimed at reducing the use of e-cigarettes.
 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

HSSP INTL signs agreement with COTY to expand e-cigarette business in Middle East and Australia
HSSP INTL signs agreement with COTY to expand e-cigarette business in Middle East and Australia
HSSP INTL(03626.HK) partners with COTY to establish e-cigarette venture in UAE, expand distribution of Heaven Gifts brand.
Oct.30 by 2FIRSTS.ai
Ukrainian Researchers Estimate E-Cigarette Black Market at 90%, Warn of About $180 Million Budget Hit in 2025
Ukrainian Researchers Estimate E-Cigarette Black Market at 90%, Warn of About $180 Million Budget Hit in 2025
Ukrainian researchers estimate that the illicit e-cigarette market makes up about 93% of total sales. Based on the National Bank of Ukraine’s exchange rate, if the black market remains at its current size, Ukraine’s state and local budgets could lose roughly $180 million in revenue in 2025.
Oct.16 by 2FIRSTS.ai
Indonesia’s Statistics Agency: Bali Leads Nation in E-Cigarette Use; Urban Usage Climbing Sharply
Indonesia’s Statistics Agency: Bali Leads Nation in E-Cigarette Use; Urban Usage Climbing Sharply
Indonesia’s statistics agency (BPS) reports in its latest publication, Statistics of People’s Welfare 2025, that Bali has the highest share of daily e-cigarette users at 1.66%, followed by East Kalimantan (1.59%) and the Special Region of Yogyakarta (1.24%). Daily vaping prevalence is higher in urban areas (0.77%) than in rural areas (0.53%).
Oct.16
2Firsts Observation|PMI Launches IQOS ILUMA i × SELETTI Limited Edition at Dubai Airport
2Firsts Observation|PMI Launches IQOS ILUMA i × SELETTI Limited Edition at Dubai Airport
2Firsts observed that Philip Morris International (PMI) has set up a large-scale IQOS display at Dubai International Airport’s duty-free area, featuring the TEREA tobacco stick series with promotional offers. The brand also showcased its limited-edition collaboration with Italian design house SELETTI — IQOS ILUMA i × SELETTI — further strengthening its premium image through artistic design.
Nov.13 by 2FIRSTS.ai
Research Report: E-Cigarette Device Market to Hit $34.29 Billion by 2031; Top Brands Now Hold Nearly Half the Share
Research Report: E-Cigarette Device Market to Hit $34.29 Billion by 2031; Top Brands Now Hold Nearly Half the Share
Market research firm LP Information has released a global e-cigarette market report forecasting that the e-cigarette device market—including both disposable and reusable devices—will reach US$34.29 billion by 2031, with a 9.4% CAGR from 2025 to 2031.
Oct.16
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.
Oct.20 by 2FIRSTS.ai